Your search returned 31 studies. (Get alerts for new studies):
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Scottsboro, Alabama
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Scottsboro, Alabama
- Comparing Patient Satisfaction With Pataday or Bepreve
Conditions: Eye Allergies
Location: Murfreesboro, Tennessee
- LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Conditions: Irritable Bowel Syndrome
Location: Murfreesboro, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Murfreesboro, Tennessee
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Murfreesboro, Tennessee
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Fayetteville, Tennessee
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Shelbyville, Tennessee
- Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chro
Conditions: Chronic Obstructive Pulmonary Disease
Location: Fayetteville, Tennessee
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Tullahoma, Tennessee
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Fayetteville, Tennessee
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hosp
Conditions: Heart Failure
Location: Tullahoma, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Murfreesboro, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Smyrna, Tennessee
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Conditions: Chronic Nonmalignant and Nonneuropathic Pain
Location: Smyrna, Tennessee
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Spring Hill, Tennessee
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Spring Hill, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Murfreesboro, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Smyrna, Tennessee
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Tullahoma, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Fayetteville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Murfreesboro, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Smyrna, Tennessee
- Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
Conditions: Diabetic Neuropathy, Painful
Location: Tullahoma, Tennessee
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Tullahoma, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Murfreesboro, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Smyrna, Tennessee
- Allopurinol Outcome Study
Conditions: Gout
Location: Spring Hill, Tennessee
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Spring Hill, Tennessee
- Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Conditions: Gout
Location: Spring Hill, Tennessee
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions: Chronic Low Back Pain
Location: Smyrna, Tennessee
|